KENYON LAWRENCE A bought OTLK
August 14, 2026 · Form 4 insider transaction
KENYON LAWRENCE A bought 101,010 shares of Outlook Therapeutics, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
101,010
Price
N/A
Total value
N/A
InsiderKENYON LAWRENCE A
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 14, 2026
Filing dateAugust 14, 2026
Shares owned after106,956
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 14, 2026, the reporting person acquired 101,010 shares of common stock and accompanying warrants to purchase 101,010 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.